[Medikit] Share Buyback and Incentive Program Introduction | July 2026

Overview of Share Buyback

Medikit plans to dispose of 12,700 shares of treasury stock on July 24, 2026, raising approximately 35.39 million yen. The disposal price is set at 2,787 yen per share, based on a reasonable valuation criterion derived from the closing market price. This share disposal is part of an incentive scheme linked to the restricted stock compensation plan for directors and officers. The targeted individuals include 17 persons, including directors, executive officers, and officers of subsidiaries, with the transfer restrictions remaining until their resignation or retirement.

Purpose and Future Outlook

This share buyback is intended to promote the sustainable enhancement of corporate value and the sharing of value with shareholders through an incentive scheme. The funds raised will serve as a source for future business development and growth strategies. The scheme includes provisions such as the setting of transfer restriction periods and conditions for releasing shares upon retirement, aiming to boost officer motivation and support long-term stable management.